Assessing the impact of limit of detection on HAI titer increase estimation in vaccine studies
Ge, Y.
Show abstract
In many laboratory assays that measure immunological quantities, a portion of the measured values fall below a limit of detection (LOD). This is also the case for the hemagglutination inhibition assay (HAI), a common method used to quantify antibodies in influenza research. The conventional approach is to treat values below the LOD as either equal to the LOD or LOD/2, which can introduce potential biases. These biases can become more pronounced when calculating compound measures such as the difference between post-vaccination and pre-vaccination antibody titers (titer increase). To address this issue, we conducted simulations using LOD measurements with LOD/2 values as the standard imputation. We then developed a new method to adjust coefficient estimates that account for the censored nature of measurements below the LOD. Applying this new method to data from an influenza vaccine cohort study, we compared the impact of vaccine dose on the titer increase of HAI. Author SummaryAnalysis of measurements obtained from widely used antibody assays frequently overlooks the underlying data structure, leading to potential biases in the results. To address this issue, we have developed a method that effectively reduces these biases.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Estimating historical disease burden and the impact of vaccination by influenza type and subtype in the United States, 2016-2020 93%
- Benefit-Risk Assessment Of COVID-19 Vaccine, Mrna (Mrna-1273) For Males Age 18-64 Years 92%
- Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study 92%
Similar papers in this journal
Similar papers in this journal
- Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design 94%
- Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel 93%
- Misclassification of yellow fever vaccination status revealed through hierarchical Bayesian modeling 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.